{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:04:46Z","timestamp":1778699086055,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.toxlet.2022.08.006","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T14:49:09Z","timestamp":1660142949000},"page":"33-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["In vitro\/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assay"],"prefix":"10.1016","volume":"368","author":[{"given":"Tim","family":"Brecklinghaus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiebke","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Duda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"Kappenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Gr\u00fcndler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Edlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemarie","family":"Marchan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Ghallab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Cadenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Rieck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nachiket","family":"Vartak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laia","family":"Tolosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 V.","family":"Castell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emina","family":"Halilbasic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anett","family":"Ullrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Zeigerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zlem","family":"Demirci Turgunbayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Damm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Seehofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Rahnenf\u00fchrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan G.","family":"Hengstler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2022.08.006_bib1","doi-asserted-by":"crossref","unstructured":"Akaike, H., 2011. Akaike\u2019s Information Criterion, in: International Encyclopedia of Statistical Science. Springer Berlin Heidelberg, pp. 25\u201325. https:\/\/doi.org\/10.1007\/978\u20133-642\u201304898-2_110.","DOI":"10.1007\/978-3-642-04898-2_110"},{"key":"10.1016\/j.toxlet.2022.08.006_bib2","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00204-019-02492-9","article-title":"Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations","volume":"93","author":"Albrecht","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2022.08.006_bib3","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.tiv.2015.07.010","article-title":"The interplay between hepatic stellate cells and hepatocytes in an in vitro model of NASH","volume":"29","author":"Barbero-Becerra","year":"2015","journal-title":"Toxicol. Vitr"},{"key":"10.1016\/j.toxlet.2022.08.006_bib4","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","article-title":"Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver","volume":"54","author":"Begriche","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.toxlet.2022.08.006_bib5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/toxsci\/kfx289","article-title":"Comparison of hepatic 2D sandwich cultures and 3d spheroids for long-term toxicity applications: a multicenter study","volume":"162","author":"Bell","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2022.08.006_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/liv.13308","article-title":"Hepatotoxicity of statins and other lipid-lowering agents","volume":"37","author":"Bj\u00f6rnsson","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.toxlet.2022.08.006_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-3180.1989.tb00845.x","article-title":"An equation to describe dose responses where there is stimulation of growth at low doses","volume":"29","author":"Brain","year":"1989","journal-title":"Weed Res"},{"key":"10.1016\/j.toxlet.2022.08.006_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109728","article-title":"The hepatocyte export carrier inhibition assay improves the separation of hepatotoxic from non-hepatotoxic compounds","volume":"351","author":"Brecklinghaus","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.toxlet.2022.08.006_bib9","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1541-0420.2005.00344.x","article-title":"Combining multiple comparisons and modeling techniques in dose-response studies","volume":"61","author":"Bretz","year":"2005","journal-title":"Biometrics"},{"key":"10.1016\/j.toxlet.2022.08.006_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00204-019-02630-3","article-title":"Inflammation-associated suppression of metabolic gene networks in acute and chronic liver disease","volume":"94","author":"Campos","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2022.08.006_bib11","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/toxsci\/kfx284","article-title":"Measures of BSEP inhibition in vitro are not useful predictors of DILI","volume":"162","author":"Chan","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2022.08.006_bib12","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1021\/acs.chemrestox.7b00025","article-title":"Evaluation of DILI predictive hypotheses in early drug development","volume":"30","author":"Chan","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxlet.2022.08.006_bib13","unstructured":"CRAN - Package DoseFinding [WWW Document], 2019. URL https:\/\/cran.r-project.org\/web\/packages\/DoseFinding\/index.html (accessed 5.10.21)."},{"key":"10.1016\/j.toxlet.2022.08.006_bib14","first-page":"95","article-title":"Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells","volume":"2","author":"Cui","year":"2010","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.toxlet.2022.08.006_bib15","first-page":"204","article-title":"Drug-induced liver disease","volume":"4\u20138","author":"Daly","year":"2017","journal-title":"Compr. Med. Chem. III"},{"key":"10.1016\/j.toxlet.2022.08.006_bib16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/dmd.111.040758","article-title":"In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans","volume":"40","author":"Dawson","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2022.08.006_bib17","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1124\/dmd.106.009670","article-title":"Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts","volume":"34","author":"Donato","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2022.08.006_bib18","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/1087057111427586","article-title":"High-content imaging technology for the evaluation of drug-induced steatosis using a multiparametric cell-based assay","volume":"17","author":"Donato","year":"2012","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.toxlet.2022.08.006_bib19","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1007\/s00204-016-1845-1","article-title":"Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man","volume":"90","author":"Dragovic","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2022.08.006_bib20","first-page":"22","article-title":"Immune-mediated drug-induced liver injury: immunogenetics and experimental models","author":"Gerussi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxlet.2022.08.006_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2022.01.020","article-title":"Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicity","author":"Ghallab","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.toxlet.2022.08.006_bib22","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.30213","article-title":"Bile microinfarcts in cholestasis are initiated by rupture of the apical hepatocyte membrane and cause shunting of bile to sinusoidal blood","volume":"69","author":"Ghallab","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2022.08.006_bib23","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3390\/cells10102516","article-title":"Spatio-temporal multiscale analysis of western diet-fed mice reveals a translationally relevant sequence of events during NAFLD progression","volume":"10","author":"Ghallab","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.toxlet.2022.08.006_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cbi.2006.11.004","article-title":"A human hepatocellular in vitro model to investigate steatosis","volume":"165","author":"G\u00f3mez-Lech\u00f3n","year":"2007","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.toxlet.2022.08.006_bib25","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1083\/jcb.100.3.965","article-title":"Nile red: a selective fluorescent stain for intracellular lipid droplets","volume":"100","author":"Greenspan","year":"1985","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.toxlet.2022.08.006_bib26","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1007\/s00204-018-2302-0","article-title":"Relevance of the incubation period in cytotoxicity testing with primary human hepatocytes","volume":"92","author":"Gu","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2022.08.006_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/hep4.1797","article-title":"Transcriptomic cross-species analysis of chronic liver disease reveals consistent regulation between humans and mice","volume":"6","author":"Holland","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.toxlet.2022.08.006_bib28","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/liv.14006","article-title":"Genetic determinants of steatosis and fibrosis progression in paediatric non-alcoholic fatty liver disease","volume":"39","author":"Hudert","year":"2019","journal-title":"Liver Int."},{"key":"10.1016\/j.toxlet.2022.08.006_bib29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/toxsci\/65.2.166","article-title":"Mechanisms of hepatotoxicity","volume":"65","author":"Jaeschke","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2022.08.006_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/toxsci\/kfs326","article-title":"Use of micropatterned cocultures to detect compounds that cause drug-induced liver injury in humans","volume":"132","author":"Khetani","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2022.08.006_bib31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3748\/wjg.v23.i2.204","article-title":"Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease","volume":"23","author":"Kostrzewski","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.toxlet.2022.08.006_bib32","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1007\/s00204-017-2045-3","article-title":"Adverse outcome pathways: opportunities, limitations and open questions","volume":"91","author":"Leist","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2022.08.006_bib33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/978-1-4939-2074-7_29","article-title":"In vitro cell culture models of hepatic steatosis","volume":"1250","author":"Levy","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.toxlet.2022.08.006_bib34","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1093\/eurheartj\/ehy182","article-title":"Adverse effects of statin therapy: perception vs. the evidence \u2013 focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract","volume":"39","author":"Mach","year":"2018","journal-title":"Eur. Heart J"},{"key":"10.1016\/j.toxlet.2022.08.006_bib35","doi-asserted-by":"crossref","first-page":"12093","DOI":"10.1074\/jbc.M510660200","article-title":"Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis","volume":"281","author":"Malhi","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2022.08.006_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2133\/dmpk.21.347","article-title":"Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: a review","volume":"21","author":"Masubuchi","year":"2006","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.toxlet.2022.08.006_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mce.2012.05.004","article-title":"FXR signaling in the enterohepatic system","volume":"368","author":"Matsubara","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.toxlet.2022.08.006_bib38","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jhep.2020.09.037","article-title":"Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis","volume":"74","author":"Mohs","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.toxlet.2022.08.006_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cotox.2019.03.001","article-title":"Human in vitro models of nonalcoholic fatty liver disease","volume":"16","author":"M\u00fcller","year":"2019","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.toxlet.2022.08.006_bib40","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.24229","article-title":"Drug induced cholestasis","volume":"53","author":"Padda","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2022.08.006_bib41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/03602532.2011.604086","article-title":"Central role of mitochondria in drug-induced liver injury","volume":"44","author":"Pessayre","year":"2012","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.toxlet.2022.08.006_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.598","article-title":"Mechanistic insights into antiretroviral drug-induced liver injury","volume":"8","author":"Pillaye","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.toxlet.2022.08.006_bib43","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s00204-017-2002-1","article-title":"Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury","volume":"91","author":"Proctor","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2022.08.006_bib44","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0891-5849(01)00632-3","article-title":"Mechanism of clofibrate hepatotoxicity: mitochondrial damage and oxidative stress in hepatocytes","volume":"31","author":"Qu","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.toxlet.2022.08.006_bib45","unstructured":"R. Core Team, 2021. A Language and Environment for Statistical Computing. R Found. Stat. Comput."},{"key":"10.1016\/j.toxlet.2022.08.006_bib46","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/toxsci\/kfh126","article-title":"Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes","volume":"79","author":"Raucy","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2022.08.006_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109353","article-title":"A mechanism of perhexiline\u2019s cytotoxicity in hepatic cells involves endoplasmic reticulum stress and p38 signaling pathway","volume":"334","author":"Ren","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.toxlet.2022.08.006_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146021","article-title":"Dose-response analysis using R","volume":"10","author":"Ritz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.toxlet.2022.08.006_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.toxlet.2022.08.006_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2019.04.003","article-title":"Road map for development of stem cell-based alternative test methods","author":"Sachinidis","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.toxlet.2022.08.006_bib51","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/s42255-021-00452-1","article-title":"Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling","volume":"3","author":"Schneider","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.toxlet.2022.08.006_bib52","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2021.11.009","article-title":"A new perspective on NAFLD: Focusing on lipid droplets","volume":"76","author":"Scorletti","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.toxlet.2022.08.006_bib53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3389\/fcell.2021.626805","article-title":"A critical perspective on 3D liver models for drug metabolism and toxicology studies","volume":"9","author":"Serras","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.toxlet.2022.08.006_bib54","first-page":"1","article-title":"A multi-parametric fluorescent assay for the screening and mechanistic study of drug-induced steatosis in liver cells in culture","volume":"2017","author":"Tolosa","year":"2017","journal-title":"Curr. Protoc. Toxicol."},{"key":"10.1016\/j.toxlet.2022.08.006_bib55","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/hep.28373","article-title":"Cholestasis-induced adaptive remodeling of interlobular bile ducts","volume":"63","author":"Vartak","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2022.08.006_bib56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.taap.2004.03.005","article-title":"Mitochondrial oxidative stress in human hepatoma cells exposed to stavudine","volume":"199","author":"Velsor","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2022.08.006_bib57","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/toxsci\/kfy058","article-title":"Prediction of drug-induced hepatotoxicity using long-term stable primary hepatic 3D spheroid cultures in chemically defined conditions","volume":"163","author":"Vorrink","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2022.08.006_bib58","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41573-019-0048-x","article-title":"Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models","volume":"19","author":"Weaver","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.toxlet.2022.08.006_bib59","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.tiv.2007.05.014","article-title":"Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells","volume":"21","author":"Westerink","year":"2007","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.toxlet.2022.08.006_bib60","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1073\/pnas.1909145117","article-title":"Identification of Ppar\u03b3-modulated miRNA hubs that target the fibrotic tumor microenvironment","volume":"117","author":"Winkler","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.toxlet.2022.08.006_bib61","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","article-title":"Predicting drug disposition via application of BCS: Transport\/absorption\/ elimination interplay and development of a biopharmaceutics drug disposition classification system","volume":"22","author":"Wu","year":"2005","journal-title":"Pharm. Res."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427422009869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427422009869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T05:27:05Z","timestamp":1759901225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427422009869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":61,"alternative-id":["S0378427422009869"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2022.08.006","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro\/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assay","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2022.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}